Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Psychopharmacology Bulletin VOL 37 Supplement No. 1 - Full Issue Stacked PDF
1
x
$
60.00
Sex Differences in Antipsychotic Related Metabolic Functioning in Schizophrenia Spectrum Disorders
1
x
$
30.00
A Failed 6-Week, Randomized, Double-Blind, Placebo-Controlled Study of Once-Daily Extended Release Quetiapine Fumarate in Patients with Acute Schizophrenia: Lessons Learned
1
x
$
30.00
Psychopharmacology Bulletin VOL 37 Supplement No. 2 - Full Issue Stacked PDF
1
x
$
60.00
Effectiveness of Clozapine use in Delaying Hospitalization in Routine Clinical Practice: A 2 year Observational Study
1
x
$
30.00
Psychopharmacology Bulletin VOL 36 Supplement No. 3 - Full Issue Stacked PDF
1
x
$
60.00
Genetics of Schizophrenia: Recent Advances
1
x
$
30.00
Efficacy of Omega-3 Fatty Acids in Mood Disorders
1
x
$
30.00
Intravenous Lidocaine Infusion for the Management of Early Postoperative Pain: A Comprehensive Review of Controlled Trials (OPEN ACCESS)
1
x
$
0.00
La guía 2016 sobre interacciones entre medicamentos psicotrópicos, Part 2
1
x
$
15.00
Pharmacology of Valproate
1
x
$
30.00
Early Positive Report of Viloxazine for a Child with Hyperkinetic Autism
1
x
$
30.00
Treatment of Autism Spectrum Disorder in Children and Adolescents
1
x
$
30.00
Gary M. Levin, PharmD: A Pharmacokinetic Drug-Drug Interaction Study of Venlafaxine and Indinavir
1
x
$
30.00
Psychopharmacology Bulletin VOL 47 No. 2, 2017 - Full Issue Stacked PDF
1
x
$
60.00
Lasmiditan for the Treatment of Migraines With or Without Aura in Adults (OPEN ACCESS)
1
x
$
0.00
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Mood Disorder
1
x
$
0.00
Vilazodone - Safety and Tolerability Profile PB VOL 44 No. 3
1
x
$
30.00
Joyce E. Myers, MD: Risperidone: Review of Its Therapeutic Utility in Depression
1
x
$
30.00
Terence A. Ketter, MD: Mood Stabilizers and Atypical Antipsychotics: Bimodal Treatments for Bipolar Disorder
1
x
$
30.00
Psychopharmacology Bulletin VOL 36 Supplement No. 1 - Full Issue Stacked PDF
1
x
$
0.00
Great Expectations in Stereochemistry: Focus on Antidepressants
1
x
$
0.00
Lori Davis, MD: Clinical and Pharmacoeconomic Evaluation of Switch to Olanzapine in Veterans with Schizophrenia or Schizoaffective Disorder
1
x
$
30.00
View Cart
Checkout
Home
Psiquiatría y Salud Integral
Volume 1 No. 1 Articles
Psiquiatría y Salud Integral VOL 1 No. 1 Articles
Sort by
Price
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Nota del Director Editorial: En vivo desde Nueva York, les presentamos Psiquiatría y Salud Integral
$
0.00
Add to cart
Details
Dr. Juan E. Mezzich y Dr. Miguel R. Jorge: ¡Bienvenidos a Psiquiatría y Salud Integral!
$
0.00
Add to cart
Details
Psiquiatría y Salud Integral: El consejo editorial de PSI incluye los siguientes psiquiatras y médicos:
$
0.00
Add to cart
Details
Utilización del nombre de los fármacos
$
0.00
Add to cart
Details
Lineamientos universales: Indíce de medicamentos para Latinoamérica
$
0.00
Add to cart
Details
Información Societaria
$
0.00
Add to cart
Details
Sin prisa y sin pausa: el estimado maestro Dr. Javier Mariátegui Chiappe
$
0.00
Add to cart
Details
Resúmenes recientes del XXI Congreso Latinoamericano de Psiquiatria/XVI Congreso Nacional de Psiquiatría, Lima, Perú en Psiquiatría, Neurología, y Medicina General
$
0.00
Add to cart
Details
Fobia social: perspectivas de diagnóstico, neurobiológicas y de tratamiento
$
0.00
Add to cart
Details
La farmacoterapia del trastorno de ansiedad social
$
0.00
Add to cart
Details
La fobia social en una muestra de pacientes Españoles con trastorno de pánico
$
0.00
Add to cart
Details
Estudio de validación de la Escala de Salud Personal (ESP) en Lima, Perú
$
0.00
Add to cart
Details
El libro negro de dosificación y monitoreo de sustancias psicotrópicas
$
30.00
Add to cart
Details
Page load link
Go to Top
